Innova Market Insights data indicates a 20% average annual growth rate in using the probiotic strain Bacillus subtilis DE111 in F&B, including supplement launches between July 2019 and June 2024. US/Canada was on the frontline, accounting for two-thirds of global launches. Between July 2023 and June 2024, more than half of launches with Bacillus subtilis DE111 were supplements. Meanwhile, the application of Bacillus subtilis DE111 was rapidly growing in various other categories, such as Sports Nutrition and Soft Drinks.